Prostate Cancer Trial, Recruiting NCT06172283 Sponsor: State University of New York at Buffalo Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06172283
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing and able to sign a written consent form agreeing to take part in the trial.
  • People who were male at birth and are at least 18 years old at the time of signing the consent form.
  • People who have measurable prostate cancer and whose condition makes them a candidate for hormone-blocking treatment (androgen deprivation therapy).
  • People whose general physical health and ability to carry out daily activities falls within an acceptable range on a standard medical scale called the ECOG scale (scores 0–1) (confirm with trial site).
  • People whose organs (such as kidneys and liver) are functioning well enough, based on blood tests taken within 10 days before starting treatment.
  • People who have stored tumour tissue available from a previous procedure, or who are willing to have a tissue sample (biopsy) taken before treatment begins.
  • People who are expected to live for at least 6 months.

Who may not be able to join:

  • People whose general health and daily functioning has declined to a level of 2 or higher on the ECOG scale (confirm with trial site, as this overlaps with inclusion criteria).
  • People who are currently taking part in another clinical trial or who have received an experimental treatment or used an experimental medical device within the past 4 weeks.
  • People who have another cancer that is currently growing or requires active treatment.
  • People who have any medical condition, previous treatment, or abnormal test result that, in the treating doctor's opinion, could affect the trial results or make participation unsafe or unsuitable.
  • People with known mental health conditions or substance use disorders that could make it difficult to follow the trial's requirements.
  • People with a known allergy, intolerance, or medical reason preventing them from receiving the contrast dye used in the CT or MRI scans required by the trial.
  • People with any other medical situation that, in the lead doctor's opinion, could make it difficult to follow the study requirements or could affect the study's goals.
  • People who are unwilling or unable to sign the written consent form.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 716-881-8918

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
State University of New York at Buffalo
Registry
ClinicalTrials.gov
Start date
5 December 2023
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Enrollment rate; Drop-out rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov